PortfoliosLab logoPortfoliosLab logo
SCHX vs. AZN
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SCHX vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Schwab U.S. Large-Cap ETF (SCHX) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SCHX achieves a 8.56% return, which is significantly higher than AZN's 0.81% return. Both investments have delivered pretty close results over the past 10 years, with SCHX having a 15.20% annualized return and AZN not far ahead at 15.85%.


SCHX

1D
0.28%
1M
0.45%
YTD
8.56%
6M
8.52%
1Y
24.19%
3Y*
21.40%
5Y*
12.87%
10Y*
15.20%

AZN

1D
-2.37%
1M
-0.71%
YTD
0.81%
6M
1.53%
1Y
28.04%
3Y*
9.54%
5Y*
12.08%
10Y*
15.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SCHX vs. AZN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SCHX
Schwab U.S. Large-Cap ETF
8.56%17.46%24.88%26.84%-19.41%26.81%20.81%31.22%-4.66%21.95%
AZN
AstraZeneca PLC
0.81%43.30%-0.62%1.44%19.14%19.66%3.12%35.68%13.86%33.10%

Correlation

The correlation between SCHX and AZN is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Nov 4, 2009

0.40

The correlation between SCHX and AZN shifts across timeframes, from 0.23 (1 year) to 0.40 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SCHX vs. AZN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SCHX
SCHX Risk / Return Rank: 6666
Overall Rank
SCHX Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
SCHX Sortino Ratio Rank: 6464
Sortino Ratio Rank
SCHX Omega Ratio Rank: 6767
Omega Ratio Rank
SCHX Calmar Ratio Rank: 6060
Calmar Ratio Rank
SCHX Martin Ratio Rank: 7272
Martin Ratio Rank

AZN
AZN Risk / Return Rank: 7373
Overall Rank
AZN Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
AZN Sortino Ratio Rank: 7373
Sortino Ratio Rank
AZN Omega Ratio Rank: 6969
Omega Ratio Rank
AZN Calmar Ratio Rank: 7474
Calmar Ratio Rank
AZN Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SCHX vs. AZN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Schwab U.S. Large-Cap ETF (SCHX) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SCHXAZNDifference
Sharpe ratioReturn per unit of total volatility

+0.87

Sortino ratioReturn per unit of downside risk

+0.85

Omega ratioGain probability vs. loss probability

1.36

1.21

+0.15

Calmar ratioReturn relative to maximum drawdown

2.69

1.83

+0.86

Martin ratioReturn relative to average drawdown

12.15

4.90

+7.25

SCHX vs. AZN - Sharpe Ratio Comparison

The current SCHX Sharpe Ratio is 1.98, which is higher than the AZN Sharpe Ratio of 1.11. The chart below compares the historical Sharpe Ratios of SCHX and AZN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SCHXAZNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.98

1.11

+0.87

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.75

0.51

+0.25

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.84

0.64

+0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

0.84

0.49

+0.35

Drawdowns

SCHX vs. AZN - Drawdown Comparison

The maximum SCHX drawdown since its inception was -34.33%, smaller than the maximum AZN drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for SCHX and AZN.


Loading charts...

Drawdown Indicators


SCHXAZNDifference

Max Drawdown

Largest peak-to-trough decline

-34.33%

-48.94%

+14.61%

Max Drawdown (1Y)

Largest decline over 1 year

-9.02%

-15.43%

+6.41%

Max Drawdown (3Y)

Largest decline over 3 years

-19.04%

-27.87%

+8.83%

Max Drawdown (5Y)

Largest decline over 5 years

-25.41%

-27.87%

+2.46%

Max Drawdown (10Y)

Largest decline over 10 years

-34.33%

-27.87%

-6.46%

Current Drawdown

Current decline from peak

-2.64%

-12.90%

+10.26%

Average Drawdown

Average peak-to-trough decline

-3.97%

-11.37%

+7.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.00%

5.75%

-3.75%

Volatility

SCHX vs. AZN - Volatility Comparison

The current volatility for Schwab U.S. Large-Cap ETF (SCHX) is 3.84%, while AstraZeneca PLC (AZN) has a volatility of 7.42%. This indicates that SCHX experiences smaller price fluctuations and is considered to be less risky than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SCHXAZNDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.84%

7.42%

-3.58%

Volatility (6M)

Calculated over the trailing 6-month period

9.44%

17.47%

-8.03%

Volatility (1Y)

Calculated over the trailing 1-year period

12.27%

25.55%

-13.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.16%

24.02%

-6.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.17%

24.94%

-6.77%

Dividends

SCHX vs. AZN - Dividend Comparison

SCHX's dividend yield for the trailing twelve months is around 1.03%, less than AZN's 2.93% yield.


PositionTTM20252024202320222021202020192018201720162015
AZN
AstraZeneca PLC
2.93%1.70%2.27%2.15%2.12%2.35%2.80%2.81%3.69%3.95%5.01%4.06%
SCHX
Schwab U.S. Large-Cap ETF
1.03%1.09%1.22%1.39%1.64%1.22%1.64%1.82%2.02%1.70%1.92%2.04%

Frequently Asked Questions


SCHX and AZN have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AZN has higher volatility (7.42%) compared to SCHX (3.84%). In terms of maximum drawdown, SCHX dropped -34.33% vs AZN's -48.94%.

SCHX currently has the higher Sharpe Ratio (1.98 vs 1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SCHX and AZN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer